<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-101164</identifier>
<setSpec>0004-0614</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Risk factors for biochemical recurrence after radical prostatectomy in patients with clinically localized prostate cancer. Implications of adjuvant treatment</dc:title>
<dc:description xml:lang="en">CONCLUSIONS: Patients who have a Gleason score &amp;#8805; 8, positive margins, pT3 tumour or a percentage of &gt;50% after prostatectomy have an increased risk of biochemical recurrence. Patients with at least 2 predictors of relapse have a probability of recurrence over 50% in the first 5 years of recurrence and should therefore be candidates for adjuvant radiotherapy(AU)</dc:description>
<dc:creator>Díez Cordero, José María</dc:creator>
<dc:creator>Hernández Fernández, Carlos</dc:creator>
<dc:creator>Rodríguez Fernández, M. Elena</dc:creator>
<dc:creator>Pozo Jiménez, Gema del</dc:creator>
<dc:creator>Paños Fagundo, Eva V</dc:creator>
<dc:creator>Herranz Amo, Felipe</dc:creator>
<dc:creator>Aragón Chamizo, Juan</dc:creator>
<dc:creator>López López, Esther</dc:creator>
<dc:creator>Piñero Sánchez, Javier</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">CONCLUSIONES: Los pacientes que después de la prostatectomía tenían un score de Gleason &amp;#8805; 8, afectación de los márgenes, estadio pT3 o un porcentaje de tumor &gt; 50% presentaron un riesgo aumentado de recidiva bioquímica. Los pacientes con al menos 2 factores predictores de recidiva tendrán una probabilidad de recidiva superior al 50% en los primeros 5 años de recidiva y por lo tanto deberían de ser candidatos a radioterapia adyuvante(AU)</dc:description>
<dc:source>Arch Esp Urol;65(1): 158-165, ene.-feb. 2012. tab, graf</dc:source>
<dc:identifier>ibc-101164</dc:identifier>
<dc:title xml:lang="es">Factores de riesgo de recidiva bioquímica después de prostatectomía radical en pacientes con cáncer de próstata clínicamente localizado. Implicaciones en el tratamiento adyuvante</dc:title>
<dc:subject>^d28620</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d28603</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d11914^s22057</dc:subject>
<dc:subject>^d11914^s22012</dc:subject>
<dc:subject>^d9557^s22012</dc:subject>
<dc:subject>^d11911^s22020</dc:subject>
<dc:subject>^d11911^s22045</dc:subject>
<dc:subject>^d11914^s22009</dc:subject>
<dc:subject>^d30193^s22020</dc:subject>
<dc:subject>^d30193^s22045</dc:subject>
<dc:type>article</dc:type>
<dc:date>201202</dc:date>
</metadata>
</record>
</ibecs-document>
